Therapeutic apheresis in myasthenia gravis patients: A six year follow- up

Therapeutic Apheresis

Volumn 3, Issue 4, 1999, Pages 298-302

  Schneidewind, J M ^a,c   Zettl, U K ^a   Winkler, R E ^a   Ramlow, W ^a   Tiess, M ^a   Hofmann, D ^a   Michelsen, A ^a   Weber, G ^a   Kinze, E M ^a   Adam, U ^a   Hauk, L ^a   Behnecke, R ^a   Klinkmann, H ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Müritz Clinic   (Germany)

^c Dialyse Gemeinschaft Nord eV ^*  (Germany)

Author keywords

1 antitrypsin; Lymphocytes; Myasthenia gravis; Protein A; Therapeutic apheresis; Thymoma

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; APHERESIS; CASE REPORT; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; THYMOMA; TREATMENT OUTCOME;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMAPHERESIS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL PROTEIN A; TREATMENT OUTCOME;

EID: 6544276593     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00151.x     Document Type: Conference Paper

References (15)

1. Gooch CL. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Rolak LA, ed. Neuroimmunology for the clinician. Boston/Oxford/Johannesburg/Melbourne/New Delhi/Singapore: Butterworth-Heinemann, 1997:263-81.
2. Protti MP, Manfredi AA, Horton RM, Bellone M, Conti-Tronconi BM. Myasthenia gravis: Recognition of a human autoantigen at the molecular level. Immunol Today 1993; 14(7):363-8.
3. Schumm F, Hohlfeld R, Melms A, Toyka KV, Drachman DB. Myasthenia gravis and myasthenic-syndrome. In: Brandt TH, Caplan LR, Dickgans J, Diener HC, Kennard C, eds. Neurological Disorders: Course and treatment. 2nd edition. San Diego: Academic Press, 1996:947-64.
4. Compston DA, Vincent SA, Newston-Davis J, Batchelor JR. Clinical, pathophysiological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980;103:579-601.
5. Gilhus NE, Aarli JA, Matre G. Myasthenia gravis: Difference between thymoma associated antibodies and cross-striational skeletal antibodies. Neurology 1984;34:246-9.
6. Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A. Myasthenia gravis: Long term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983;33:1316-21.
7. Schneidewind JM, Ramlow W, Winkler RE, Tiess M, Döcke W, Volk HD, Michelsen A, Hofmann D, Weber G, Prophet H, Kinze EM, Müller W, Klinkmann H. Changes in lymphocytic subpopulations during apheresis treatment (abstract). Ther Apher 1999;3:137.
8. Iida T, Tanaka K, Kitamura M. Two cases of myasthenia gravis with improvement of clinical symptoms by plasmapheresis. Jpn J Kidney Dial 1987;22:735-9.
9. Newston-Davis J. Plasma exchange in myasthenia gravis. Plasma Ther Transfus Technol 1979;1:17-25.
10. Sawada K, Machelsky PS, Koo AP, Mitsumoto H. Myasthenia gravis therapy: Immunoadsorption may eliminate need for plasma products. Cleveland Clin J Med 1993;60(1):60-4.
11. Heininger K, Gaczkowski A, Hartung HP, Borberg H, Toyka KV. A new semi-selective procedure in therapeutic plasma exchange for myasthenia gravis. In: Bambauer R, Machelsky PS, Falkenhagen D, eds. Therapeutic plasma exchange and selective plasma separation. Stuttgart/New York: Schattauer, 1987:393-8.
12. Szpirt W, Somnier F, Gammeltorf S. Removal of anti-acetylcholine receptor antibodies by immunoadsorption to protein A column. In: Bambauer R, Machelsky PS, Falkenhagen D, eds. Therapeutic plasma exchange and selective plasma separation. Stuttgart/New York: Schattauer, 1987: 385-91.
13. Grob D, Simpson D, Mitsumoto H, Hoch B, Mokhtarian F, Bender A, Greenberg M, Koo A, Nakamyama S. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995;45(2):338-44.
14. Köhler W, Bucka C, Hertel G. Immunoadsorption bei Myasthenia gravis. Aktuel Neurolog 1998;Suppl. 2:S57-61
15. Kadar JG, Prusel M, Spaeth PJ. Immunological effects of therapeutic immunoadsorption with respect to biocompatibility. Transfus Sci 1998;19(Suppl.):9-23.